Lovastatin for Treatment of Brain Arteriovenous Malformations
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1244 participants.
Also called NCT04297033
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 1,244 participants
- Sponsor
- Registry
-
NCT04297033
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT04297033. Randomized; double masking; primary purpose treatment. Start 2021-01-01 (anticipated); primary completion 2024-06-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Lovastatin for Treatment of Brain Arteriovenous Malformations
- Condition
- Cerebral Arteriovenous Malformation
- Intervention (Drug)
- Lovastatin
- Intervention (Drug)
- Placebo
- Lead sponsor
- Beijing Tiantan Hospital
Record details
- Record id
cardio:ct-nct04297033- Content hash
6e306faed7a80de079709779386f60efb8e6005457002e5d6319d8a1af0cc186